Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app save more newborns? large study tests real-time feedback for resuscitation

NCT ID NCT05963516

Knowledge-focused Sponsor: University of North Carolina, Chapel Hill Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a mobile health app called LIVEBORN can help nurse midwives improve how they support newborns who have trouble breathing right after birth. Over 14,000 newborns and their nurses took part. The app gave either real-time guidance or a summary after the event to see which worked better. The goal was to learn how to make newborn resuscitation safer and more effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14,680 people

The number who actually took part.

Started

Aug 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Newborns admitted to a participating health facility who meet the following criteria: Inclusion criteria: * All in-born neonates, either liveborn or intrapartum (i.e., fresh) stillborn, regardless of multiple gestation or maternal complication. Exclusion criteria: * Less than 28 weeks completed gestation (or if gestational age is unknown, birth weight \<1,000 grams), * outborn, * known congenital anomaly, * antepartum (i.e., macerated) stillbirth. Nurse midwives employed at a participating health facility who meet the following criteria: Inclusion criteria: * All midwives and nurses functioning in the role of a midwife who care for newborns at the time of birth during the course of their regular employment. Exclusion criteria: * Unwillingness to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Respiratory depression neonatal are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neonatal respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Respiratory depression neonatal

Contacts and locations

Locations

  • Binza

    Kinshasa, Democratic Republic of the Congo

  • Bondo

    Kinshasa, Democratic Republic of the Congo

  • Kingasani

    Kinshasa, Democratic Republic of the Congo

  • Saint Gabriel

    Kinshasa, Democratic Republic of the Congo

More trials for these conditions

Other studies related to the condition(s) this trial covers.